Programme

As in previous years, the programme will be of interest to clinical investigators from across the globe to review current research and discuss its implications for HIV management strategies. Although there have been significant advances in treatment, new challenges have now appeared. This Congress has moved into areas beyond treatment to look at prevention and cure. The role of people living with HIV in treatment decisions and self-management will feature and we look forward to perspectives in the programme from the community.
 
The Scientific Programme will run from Sunday 10 November to Wednesday 13 November 2024. Please see below preliminary topics to be discussed. To view the preliminary programme schedule please click here.

Keynote Lectures
PrEP therapeutic agents – what’s on the horizon and access?
Artificial Intelligence and digital technologies: their role in future HIV research, treatment and care
HIV Cure: Lessons learnt and prospects for the future
Congress scientific sessions will include:
Stigma in HIV, past, present and future: Stereotyping patients: impact on HIV treatment
Real life implementation of DoxyPeP: now and future
Ethics in trials of HIV cure
Experience in the implementation of long acting: resource constrained and non-resource constrained scenarios
New Treatments and Future Combinations
Clinical case study session
INSTI resistance and testing
Addressing the Needs of Older Patients in HIV Care
Managing Cardiometabolic risk in HIV: the role of old and new drugs
Elimination of HIV Vertical Transmission Across the World
2024 Guidelines: An update and CV risk recommendations


We are delighted to be collaborating with the following organisations for HIV Glasgow 2024 programme planning and development:

British HIV Association
Euroguidelines in Central and Eastern Europe (ECEE) Network Group
European AIDS Clinical Society
European AIDS Treatment Group
International AIDS Society
University of Liverpool DDI team
 
There is also space in the scientific programme for oral papers and hot topics, selected from submitted abstracts.
 
Further information will be available soon. Please sign-up to our newsletter to receive all Congress alerts.